악성 고혈압 치료 Malignant Hypertension Treatment & Management Updated: Jan 13, 2017 Author: John D Bisognano, MD, PhD, FACP, FACC; Chief Editor: Vecihi Batuman, MD, FASN Malignant Hypertension Sections Malignant Hypertension Overview Background Pathophysiology and Etiology Prognosis Patient Education … Continued
Two drugs under consideration for inclusion in antiretroviral therapy (ART) regimens for human immunodeficiency virus (HIV) infection are dolutegravir (DTG) and tenofovir alafenamide fumarate (TAF). There are limited data on their use in low- and middle-income countries. NEJM 8/2019 인간 … Continued
Although systolic blood pressure elevation had a greater effect on outcomes, both systolic and diastolic hypertension independently influenced the risk of adverse cardiovascular events, regardless of the definition of hypertension (≥140/90 mm Hg or ≥130/80 mm Hg). (Funded by the … Continued
장애 사춘기 여아 월경 억제치료를 종합 경구용 피임약(COCPs)으로도 하기도 하지만 종합 경구용 피임약(COCPs)과 Depo-provera( Depo Medroxyprogeterone Acetate)근육주사로 동시하면 치료 효과가 더 좋다고 NEJM Journal Watch, Pediatrics and Adolescent Medicine 8/2019 Menstrual suppression in disabled adolescent girls can be treated with … Continued
당뇨병 자가 면역체가 있는 당뇨병 발생 고 위험성 사람들을 Teplizumab으로 예방치료 하면 1형 당뇨병 발생 시기를 지연시킬 수 있다고 NEJM Journal Watch, Pediatrics and Adolescent Medicine 8/2019 Preventive treatment with Teplizumab in people at high risk of developing diabetes with diabetic … Continued
기관지 천식, 편두통, 당뇨병 등 육체적 질병을 만성적으로 앓는 아이들에게 정신 건강 문제가 더 잘 생길 수 있다고. NEJM Journal Watch, Pediatrics and Adolescent Medicine 8/2019 Children who chronically suffer from physical illnesses such as bronchial asthma, migraines, and diabetes … Continued
소아 폐렴을 치료 할때 통상적으로 피 세균 배양 검사를 곡 해야 하나 휵막강 삼출액이 있는 폐렴이나 중등도나 중증도 지역 감염 폐렴을 앓을 때는 피 세균 배양검사를 하도록 권장한다. NEJM Journal Watch, Pediatrics and Adolescent Medicine 8/2019 When treating pneumonia in … Continued
생후 29일 부터 90일 된 영아가 요로 감염에 걸렸을 때 요척주 천자 뇌척수 액 검사를 하는 것은 담당 의사의 판단에 따르것이 좋다고 한다 . NEJM Journal Watch, Pediatrics and Adolescent Medicine 8/2019 It is said that when a 29 to … Continued
Ibrutinib–rituximab treatment previously untreated CLL(Chronic Lymphocytic Leukemia) or SLL In this randomized trial involving patients 70 years of age or younger who had previously untreated CLL or SLL and did not have chromosome 17p13 deletion, ibrutinib–rituximab treatment was superior to … Continued
Membranous nephropathy rituximab or Cyclosporine treatment B-cell anomalies play a role in the pathogenesis of membranous nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for inducing and maintaining a complete or partial remission of proteinuria … Continued